Rituximab Maintenance Versus Wait and Watch after Four Courses of R-DHAP Followed By Autologous Stem Cell transplantation in Previously Untreated Young Patients with Mantle Cell Lymphoma: First Interim Analysis of the Phase III Prospective Lyma Trial, a L

Affiliation auteurs!!!! Error affiliation !!!!
TitreRituximab Maintenance Versus Wait and Watch after Four Courses of R-DHAP Followed By Autologous Stem Cell transplantation in Previously Untreated Young Patients with Mantle Cell Lymphoma: First Interim Analysis of the Phase III Prospective Lyma Trial, a L
Type de publicationJournal Article
Year of Publication2014
AuteursLe Gouill S, Thieblemont C, Oberic L, Bouabdallah K, Gyan E, Damaj G, Ribrag V, Bologna S, Gressin R, Casasnovas O, Haioun C, Solal-Celigny P, Maisonneuve H, Van Den Neste E, Moreau A, Bene MC, Salles G, Tilly H, Lamy T, Hermine O
JournalBLOOD
Volume124
Date PublishedDEC 6
Type of ArticleMeeting Abstract
ISSN0006-4971
DOI10.1182/blood.V124.21.146.146